By Ria Kakkad (Drug Target Review)2023-01-12T11:30:00
Researchers found that proteins made by stem cells that regenerate the cornea could be new targets for treating dry eye disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T09:00:00Z
2026-07-09T12:00:00Z
2026-07-07T12:00:00Z
2026-07-01T13:30:00Z
Contributor Carrie Maynard and Dr Veronica Fowler
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2023-04-12T15:15:18
Sponsored by Cellistic
2024-01-09T09:30:19
Sponsored by Sartorius
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-07-03T10:28:23
Sponsored by Merck
Site powered by Webvision Cloud